vimarsana.com

Latest Breaking News On - Dany habr - Page 1 : vimarsana.com

How Pfizer Prioritizes Diversity When Implementing Multiple Myeloma Trials

How Pfizer Prioritizes Diversity When Implementing Multiple Myeloma Trials
clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.

Pfizer Unveils Oncology Advances at ASCO 2023 Meeting

Pfizer Unveils Oncology Advances at ASCO 2023 Meeting
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

03 13 23 -- Pfizer Exec On Pharma s Role In Improving Health Literacy

03/13/23 Clinical Leader Newsletter

Improving Health Literacy Breaking Barriers To Quality Cancer Care

The American Cancer Society and Pfizer Launch Community Grants Focused on Reducing Prostate Cancer Disparities Among Black Men

The American Cancer Society and Pfizer Launch Community Grants Focused on Reducing Prostate Cancer Disparities Among Black Men News provided by Share this article Share this article ATLANTA, March 3, 2021 /PRNewswire/ The American Cancer Society and Pfizer Global Medical Grants are collaborating and have awarded a new competitive grant opportunity focused on addressing prostate cancer disparities impacting Black men. The grants, funded by Pfizer Global Medical Grants and overseen by the American Cancer Society, are aimed at reducing gaps in care and barriers to treatment, and were awarded through a competitive selection process. Cancer is a disease that affects everyone, but it doesn t affect everyone equally. Blacks experience more illness, worse outcomes, and premature death compared to whites in the United States. Further, Black people have the highest death rate and shortest survival of any racial/ethnic group in the United States for most cancers. Black men also have th

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.